IP Library Granted Patent US 11,285,109
Granted Patent B2
US 11,285,109 · App. 17/259,690 · Granted Mar 29, 2022

Microsphere comprising PLGA or PLA in which a biologically active substance is uniformly dispersed and a sustained release formulation comprising the same

Inventors: Masakazu Enomura (Izumi, JP); Kaeko Araki (Izumi, JP)
Assignee: M. TECHNIQUE CO., LTD.
A61K9/1647
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,285,109
App. No.
17/259,690
Granted
Mar 29, 2022
Kind
B2
Abstract

The present application provides a microsphere comprising a lactic acid-glycolic acid copolymer (PLGA) or polylactide (PLA) as a main component, in which a biologically active substance is uniformly dispersed, wherein an average volume-based particle diameter of the microsphere is 1 μm or more and 150 μm or less, and a variation coefficient of area ratios in six regions is 0.35 or less, wherein the area ratios in six regions are calculated by (s/A)×100 (%) wherein the six regions are prepared by preparing a cross section observation sample obtained by cutting the microsphere; observing the cross section observation sample with an electron microscope at a magnification capable of confirming the biologically active substance in the microsphere or a higher magnification; and dividing the electron microscope observation image into six regions; and A is an area of a respective divided region, and s is a sum of cross section areas of the biologically active substance included in the respective divided region. The microsphere of the present invention can appropriately control the initial release amount of the biologically active substance and its release rate during a subsequent release period, and can continuously release the biologically active substance in vivo for a predetermined period of time.

Claims (10)

1. A microsphere comprising a lactic acid-glycolic acid copolymer (PLGA) or polylactide (PLA) as a main component, in which a biologically active substance is uniformly dispersed,

wherein an average volume-based particle diameter of the microsphere is 1 μm or more and 150 μm or less, and

a variation coefficient of area ratios of an area of the biologically active substance to a cross-section area of the microsphere in six regions of the microsphere is 0.35 or less.

2. The microsphere according to claim 1 , wherein the biologically active substance is a lipophilic biologically active substance.

3. The microsphere according to claim 1 , wherein an average volume-based particle diameter of the dispersed biologically active substance is 5 nm to 500 nm.

4. The microsphere according to claim 1 , wherein a content of the biologically active substance in the microsphere is 0.35 to 1.5% by mass.

5. A sustained release formulation comprising the microsphere according to claim 1 .

6. A sustained release formulation comprising the microsphere according to claim 2 .

7. A sustained release formulation comprising the microsphere according to claim 3 .

8. A sustained release formulation comprising the microsphere according to claim 4 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2021
From: ENOMURA, MASAKAZU; ARAKI, KAEKO
To: M. TECHNIQUE CO., LTD.
Reel/Frame 054894/0088 →
Priority Claims (1)
WO PCT/JP2020/018731 · May 8, 2020 · international
Continuity (1)
Related Publication 20210346297A1 · Nov 11, 2021
Cited By (2)
US 12,201,728 US 12,329,853